🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
This is a feasibility study evaluating the use of a mathematical model to p...
Status
Completed
Location
University of New Mexico Comprehensive Cancer Center
Start Date
2015-06-02
Trial ID
NCT03983538
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This phase 3 trial compares the addition of nivolumab to chemotherapy (carb...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2020-11-17
Trial ID
NCT04444921
Treatments Being Tested
This is a prospective, single-arm trial. The main purpose of the study is t...
Status
Recruiting
Location
Zhejiang Provincial People's Hospital
Start Date
2024-11-15
Trial ID
NCT06722911
Treatments Being Tested
This study will evaluate the bioavailability between the veliparib tablet f...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-11-15
Trial ID
NCT03400306
Treatments Being Tested
A randomised open-label pilot study to assess the safety and efficacy of tr...
Status
Terminated
Location
Aalborg University Hospital
Start Date
2011-05
Trial ID
NCT01899235
Treatments Being Tested
This is a single arm, open label Phase II clinical trial to evaluate the ef...
Status
Unknown
Location
Fudan University
Start Date
2021-12-01
Trial ID
NCT05138159
This is a pilot phase 1b study to investigate the safety and side effects o...
Status
Completed
Location
University of California, San Diego
Start Date
2018-08-15
Trial ID
NCT02776917
Treatments Being Tested
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024